Heart Failure with Preserved Ejection Fraction, An Issue of Cardiology Clinics

1st Edition, Volume 40-4 - October 13, 2022
Editors: Scott L. Hummel, Matthew C. Konerman
Language: English
Hardback ISBN:
9 7 8 - 0 - 3 2 3 - 9 3 9 8 1 - 2
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 9 3 9 8 2 - 9

In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection… Read more

Heart Failure with Preserved Ejection Fraction, An Issue of Cardiology Clinics

Purchase options

Info / Buy

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Request a sales quote

In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection Fraction. Top experts in the field cover key topics such as risk factors for heart failure with preserved ejection fraction (HFpEF); cardiopulmonary stress testing in HFpEF; hemodynamic assessment in HFpEF; the role of multi-modality imaging in the evaluation of HFpEF; and more.

Cover image
Title page
Table of Contents
Copyright
Contributors
Forthcoming Issues
Preface
Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction
Key points
Epidemiology
Clinical presentation and diagnostic criteria
Evaluation for Alternative Diagnoses
Addressing misconceptions about heart failure with preserved ejection fraction diagnosis
An overview of heart failure with preserved ejection fraction pathophysiology: four major themes
Suggested initial diagnostic and therapeutic approach to heart failure with preserved ejection fraction
Summary
Clinics care points
Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies
Key points
Introduction
Summary and future directions
Clinics care points
Disclosure
Approach to Echocardiography in Heart Failure with Preserved Ejection Fraction
Key points
Introduction
Summary
Clinics care points
Disclosure
The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction
Key points
Initial evaluation and establishing the diagnosis of HFpEF
Identification of specific phenotypes of HFpEF
Imaging of extracardiac organs in HFpEF
Summary
Clinics care points
Conflict of interest/disclosures
Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction
Key points
Introduction
Performing an invasive exercise hemodynamics
Normal hemodynamic ranges at rest and with exercise
Interpretation of specific hemodynamic signatures
Other assessments
Summary
Clinics care points
Sources of Funding
Disclosures
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction
Key points
Introduction
Summary
Clinics care points
Disclosure
Funding statement
Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction
Key points
Introduction
Reduced cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
Exercise training
Summary
Clinics care points
Disclosures
Device Therapy for Heart Failure with Preserved Ejection Fraction
Key points
Introduction
Summary
Clinics care points
Disclosure
Financial support
Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction
Key points
Introduction
Summary
Disclosures
Sources of funding
Clinics care points
Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
Key points
Introduction
How should pulmonary hypertension-heart failure with preserved ejection fraction be defined?
Is pulmonary hypertension-heart failure with preserved ejection fraction common?
What are the clinical implications of pulmonary hypertension in heart failure with preserved ejection fraction?
How can pulmonary arterial hypertension and pulmonary hypertension-heart failure with preserved ejection fraction be differentiated?
Are there treatment options for patients with pulmonary hypertension-heart failure with preserved ejection fraction?
Summary
Clinics care point
Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an “Old” Disease
Key points
Introduction
History of cardiac amyloidosis
Pathophysiology and epidemiology
Staging of transthyretin-cardiac amyloidosis
Symptoms and clinical findings
Clinical findings (biomarkers, echo, magnetic resonance imaging , scintigraphy, biopsy, and genetic testing)
Therapy
Summary and conclusion
Clinics care points
Disclosure

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Heart Failure with Preserved Ejection Fraction, An Issue of Cardiology Clinics

Purchase options

Save 50% on book bundles

Institutional subscription on ScienceDirect

Scott L. Hummel

Matthew C. Konerman